Development of a Multicomponent Intervention to Prevent Alzheimer's Disease
Recent advances in vascular risk management have successfully reduced the prevalence of Alzheimer's Disease (AD) in several epidemiologic investigations. It is now widely accepted that cerebrovascular disease is both directly and indirectly involved in AD pathogenesis. Herein, we review the non...
Main Authors: | Satoshi Saito, Yumi Yamamoto, Masafumi Ihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00490/full |
Similar Items
-
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
by: Satoshi Saito, et al.
Published: (2021-02-01) -
New therapeutic approaches for Alzheimer’s disease and cerebral amyloid angiopathy
by: Satoshi eSaito, et al.
Published: (2014-10-01) -
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
by: Masashi Tanaka, et al.
Published: (2019-04-01) -
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
by: Saito, Satoshi
Published: (2017) -
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
by: Satoshi Saito, et al.
Published: (2017-04-01)